Digital Health Startups

futuresTHRIVE builds AI-based digital mental health screening tools for children and adolescents, collecting early data on factors such as adverse childhood experiences, anxiety, depression, and suicidality. Its screeners are distributed to healthcare practitioners, schools, and mental health practices to support early identification and continuous care.

1 investor

Fyodor Biotechnologies makes a non-invasive Urine Malaria Test that detects malaria from a urine sample without blood, designed for point-of-care and home use. The test has been validated with research partners and holds CE Mark and regulatory approvals in several African countries.

1 investor

GLNK provides healthcare data intelligence for life sciences organizations, offering profiles of healthcare providers, institutional data, payments tracking, medical device utilization metrics, and prescribing patterns across the US healthcare ecosystem.

1 investor

Gabar (Gabarx) is a biopharmaceutical company developing small-molecule drug candidates for central nervous system disorders such as anxiety and depression, drawing on deuterium-modified molecule chemistry. Its work spans clinical development, regulatory strategy, and CMC/quality across multiple therapeutic indications.

1 investor

Gainwell Technologies provides cloud-ready technology and services to modernize Medicaid and other public health and human services programs in the United States, serving members, providers, and government program teams. Its offerings focus on reducing program complexity, surfacing data insights, and lowering costs for healthcare administration.

1 investor

HIS Solutions is a digital marketing agency based in Kuala Lumpur that offers branding, content creation, and digital services including website development and SEO optimization for businesses.

1 investor

Inventum Biotech develops software solutions for analytical, multimodal, and AI-based applications focused on preventing and managing non-communicable diseases using data and analytics.

1 investor

Gamma Diagnostics develops diagnostic tests based on Gamma Prime Fibrinogen (GPF), a blood biomarker for assessing inflammation and predicting cardiovascular and infectious disease outcomes. The company serves clinicians and healthcare providers seeking improved patient risk stratification and treatment planning.

1 investor

GastroCare Partners is a management services organization (MSO) for gastroenterology practices, providing administrative support, capital, recruitment, and operational management so physicians can focus on patient care. It operates a network of GI practices across the United States and offers access to advanced endoscopic treatments and clinical research.

1 investor

Gastro Health is a healthcare provider offering gastroenterology services, including screenings such as colonoscopies, to patients. The page presents a patient story emphasizing the importance of colon cancer screening based on family history.

1 investor

Gather Group provides an enterprise platform that identifies care needs, screens risks, delivers customised clinical guidance, and coordinates care networks to help patients self-manage their care at home. It serves healthcare organisations aiming to improve patient outcomes and reduce health system costs.

1 investor

GattaCo develops a blood collection device (A-PON) that uses passive elution to separate lab-quality liquid plasma from a self-collected finger-stick sample, which can then be mailed to a central lab for testing. The technology targets testing labs, clinical studies, and point-of-use settings, enabling remote blood collection without phlebotomists or centrifugation.

1 investor

Gavi, the Vaccine Alliance is a public-private partnership that funds and supports immunisation programmes to vaccinate children against infectious diseases in lower-income countries. It supports vaccines against 20 diseases and strengthens health and immunisation systems across 78 partner countries.

1 investor

Seattle's LGBTQ+ Center is a community organization providing health services, wellness programs, youth support, and arts initiatives for LGBTQ individuals in the Seattle area. The organization operates as the leading HIV/STI testing facility in King County and offers services including healthcare navigation, PrEP support, and resource connections.

1 investor

CcHUB Growth Capital is an early-stage venture fund investing between ₦10 million and ₦30 million in seed and early-stage for-profit technology startups building solutions to local challenges in Nigeria. It provides funding, business advisory, and network connections to help portfolio companies scale and attract follow-on funding.

1 investor

GeBBS Healthcare Solutions provides technology-enabled Revenue Cycle Management for healthcare organizations, combining agentic AI with RCM professionals to handle patient access, coding, billing, denials, and accounts receivable. Its services aim to reduce manual effort, minimize denials, and accelerate reimbursement to improve cash flow and financial control.

1 investor

Gelesis develops an oral superabsorbent hydrogel platform (OHS) built from naturally derived materials that works locally in the GI tract to influence satiety signals and support metabolic health. Its product Plenity is a clinically studied aid for weight management in overweight or obese adults with a BMI of 25 to 40 when combined with diet and exercise.

1 investor

GENinCode provides genomic testing for cardiovascular disease prevention and diagnosis using monogenic and polygenic risk assessment to identify patient risk and enable targeted preventive treatment. The company also offers testing for ovarian cancer surveillance, leveraging its proprietary software platform to combine genetic profiles with clinical risk factors.

1 investor

GenDx is a molecular diagnostics company specializing in HLA typing and other reagents and software for pre- and post-transplant testing in diagnostic laboratories. It serves the transplantation and personalized healthcare field, offering NGS-based HLA typing products, software, and educational support.

1 investor

Gene Solutions is a biotechnology company that develops genetic testing solutions using Next-Generation Sequencing and artificial intelligence for reproductive health, clinical oncology, and multi-cancer screening. The company serves healthcare providers and patients seeking precision medicine through advanced genomic profiling and early cancer detection.

1 investor

A biotech company offering gene expression analysis tools for blood-based biomarker detection across multiple cancer types. The company develops molecular signatures and liquid biopsy solutions for biopharma, diagnostics, and CRO partners.

1 investor

Genedrive Diagnostics develops and commercialises a rapid point-of-care pharmacogenetic testing platform that detects genetic variants to guide personalised medicine decisions in emergency healthcare. The UK-based company's tests help clinicians tailor drug choices based on a patient's genetics.

1 investor

GeneDx provides advanced genetic testing and clinical interpretation services to help clinicians diagnose rare and inherited genetic disorders, with AI-driven genomic intelligence that supports patient care decisions and accelerates research and drug discovery.

1 investor

GeneralPractice.AI is a platform for primary care clinicians that generates personalized prevention and lifestyle medicine plans during routine consultations. It helps GPs deliver structured, evidence-based management plans for chronic disease prevention and health optimization without adding administrative burden.

1 investor